Nystatin adverse effects

The two azoles most commonly used topically are clotrimazole and miconazole several others are available (see Preparations Available). Both are available over-the-counter and are often used for vulvovaginal candidiasis. Oral clotrimazole troches are available for treatment of oral thrush and are a pleasant-tasting alternative to nystatin. In cream form, both agents are useful for dermatophytic infections, including tinea corporis, tinea pedis, and tinea cruris. Absorption is negligible, and adverse effects are rare. 

Adverse effects associated with oral administration of nystatin include mild nausea, diarrhea, and occasional vomiting. Topical application is nonirritating, and allergic contact hypersensitivity is exceedingly uncommon. Topical amphotericin is well tolerated and only occasionally locally irritating. Hypersensitivity is rare. The drug may cause a temporary yellow staining of the skin, especially when the cream vehicle is used. 

Adverse Effects. Nystatin is generally well tolerated when applied locally. Systemic absorption through mucous membranes may cause some gastrointestinal disturbances (nausea, vomiting, diarrhea), but these side effects are generally mild and transient. Topical use of butenafine, naftifine, and tolnaftate is likewise safe, although local burning and irritation of the skin may occur in some individuals. 

Nystatin [nye STAT in] is a polyene antibiotic its structure, chemistry, mode of action, and resistance resemble those of amphotericin B. Its use is restricted to topical treatment of Candida infections because of its systemic toxicity. The drug is negligibly absorbed from the gastrointestinal tract, and it is never used par-enterally. It is administered as an oral agent ( swish and swallow ) for the treatment of oral candidiasis. Excretion in the feces is nearly quantitative. Adverse effects are rare because of its lack of absorption, but occasionally nausea and vomiting occur. 

In two patients with thymoma associated with myasthenia gravis, who both had recurrent oral candidiasis after thymectomy, radiotherapy, and chemotherapy levamisole was added as adjunctive therapy in combination with oral nystatin (5). Oral candidiasis responded favorably and substantial relief was obtained, with a concurrent increase in T cells and CD4/CD8 ratio, suggesting restoration of T cell immunity. Adverse effects were not mentioned. 

An oral suspension that contains 100,000 units/ml of nystatin is given fom times a day. Premature and low-birth-weight neonates should receive 1 mL of this preparation, infants 2 mL, and children or adults 4 to 6 mL per dose. Older children and adults should be instructed to swish the drug around the mouth and then swallow. If not otherwise instructed, the patient may expectorate the bitter liquid and fail to treat the infected mucosa in the posterior pharynx or esophagus. Nystatin suspension is usually effective for oral candidiasis of the immunocompetent host. Other than the bitter taste and occasional complaints of nausea, adverse effects are uncommou. A 200,000-unit troche (mycostatin pastilles) is available for the treatment of oral candidiasis, and a 500,000-unit oral tablet is sold for the treatment of nonesophageal membrane G1 candidiasis. 

Nystatin (e.g., Mycostatin) DOC Intestinal Candida or thrush (oral Candidst). Few adverse effects reported when administered orally. ... 

---